Russell Investments Group Ltd. Raises Stock Position in Haleon plc (NYSE:HLN)

Russell Investments Group Ltd. lifted its position in shares of Haleon plc (NYSE:HLN) by 0.7% during the 4th quarter, Holdings Channel.com reports. The fund owned 966,555 shares of the company’s stock after buying an additional 6,784 shares during the period. Russell Investments Group Ltd.’s holdings in Haleon were worth $7,955,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also modified their holdings of HLN. Pinnacle Bancorp Inc. grew its holdings in Haleon by 853.4% in the fourth quarter. Pinnacle Bancorp Inc. now owns 4,767 shares of the company’s stock valued at $39,000 after purchasing an additional 4,267 shares during the last quarter. NBC Securities Inc. purchased a new position in Haleon during the 3rd quarter valued at about $82,000. Hoxton Planning & Management LLC acquired a new position in Haleon during the fourth quarter worth about $85,000. Rehmann Capital Advisory Group purchased a new stake in shares of Haleon in the third quarter valued at about $91,000. Finally, Keel Point LLC acquired a new stake in shares of Haleon in the third quarter valued at approximately $98,000. Institutional investors and hedge funds own 6.67% of the company’s stock.

Wall Street Analyst Weigh In

HLN has been the subject of several research reports. Argus restated a “buy” rating on shares of Haleon in a research report on Tuesday, March 26th. HSBC initiated coverage on Haleon in a report on Wednesday, April 17th. They issued a “buy” rating for the company. Two research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy”.

Haleon Stock Performance

Shares of NYSE HLN opened at $8.33 on Wednesday. The company has a debt-to-equity ratio of 0.53, a current ratio of 1.04 and a quick ratio of 0.73. The company has a market cap of $38.04 billion, a PE ratio of 27.77, a price-to-earnings-growth ratio of 2.19 and a beta of 0.28. The company has a 50-day simple moving average of $8.34 and a 200-day simple moving average of $8.29. Haleon plc has a 12 month low of $7.70 and a 12 month high of $8.98.

Haleon Dividend Announcement

The firm also recently declared a semi-annual dividend, which will be paid on Thursday, May 16th. Shareholders of record on Friday, March 15th will be issued a $0.1064 dividend. The ex-dividend date is Thursday, March 14th. This represents a yield of 1.8%. Haleon’s dividend payout ratio (DPR) is presently 70.00%.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.